The Journal of Medical Microbiology, Vol 48, Issue 11 1005-1010, Copyright © 1999 by Society for General Microbiology

JOURNAL ARTICLE

Factors affecting the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice

K. Kimura, S. Miyazaki, K. Tateda, T. Matsumoto, S. Tsujimoto and K. Yamaguchi
First Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.

In order to examine several factors that may affect the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice, bacteria were prepared in a free suspension or bound to fetal mouse cells. Immunosuppression was induced in five strains of mice (ICR, C57BL/6, BALB/c, C3H/He and CBA/J) by injection of cyclophosphamide (200 mg/kg body weight), 2 days before infection. Impairment of mucociliary clearance was induced by intranasal instillation of formalin. Mice were then infected with various doses and strains of the organism. Although no significant differences were observed between either form of inoculum, pretreatment with formalin plus cyclophosphamide was associated with a significant increase in lung bacterial counts. In particular, cyclophosphamide treatment was associated with a high mortality in mice infected with several strains of S. aureus irrespective of their toxin production profiles. Histopathological examination demonstrated that in mice treated with formalin plus cyclophosphamide, clusters of bacteria were observed in lung parenchyma, associated with a mild accumulation of inflammatory cells at day 2 and extensive cell infiltration at day 7. CBA/J mice represented the most susceptible strain among those examined, with 10(4)- and 10(2)-fold higher bacterial counts in the lungs at days 3 and 5, respectively. These results indicate that neutropenia and impaired mucociliary clearance are major factors that influence the severity of S. aureus pneumonia in mice. Analysis of the role of genetic background in enhancement of vulnerability to infection is warranted in future studies.

This article has been cited by other articles:

				J. P. Mizgerd and S. J. Skerrett Animal models of human pneumonia Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L387 - L398. [Abstract] [Full Text] [PDF]

				J. B. Wardenburg, R. J. Patel, and O. Schneewind Surface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia Infect. Immun., February 1, 2007; 75(2): 1040 - 1044. [Abstract] [Full Text] [PDF]